Market Closed - Swiss Exchange 11:30:41 2024-05-31 am EDT 5-day change 1st Jan Change
80.34 CHF +0.17% Intraday chart for Alcon Inc. -2.05% +22.39%
Sales 2024 * 9.99B 9.01B Sales 2025 * 10.66B 9.62B Capitalization 43.96B 39.65B
Net income 2024 * 930M 839M Net income 2025 * 1.2B 1.08B EV / Sales 2024 * 4.7 x
Net Debt 2024 * 3B 2.71B Net Debt 2025 * 1.73B 1.56B EV / Sales 2025 * 4.28 x
P/E ratio 2024 *
48.4 x
P/E ratio 2025 *
39 x
Employees 25,000
Yield 2024 *
0.32%
Yield 2025 *
0.38%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.17%
1 week-2.05%
1 month+13.00%
3 months+6.86%
6 months+21.88%
Current year+22.39%
More quotes
1 week
79.44
Extreme 79.44
82.58
1 month
70.98
Extreme 70.98
83.34
Current year
62.24
Extreme 62.24
83.34
1 year
61.28
Extreme 61.28
83.34
3 years
55.22
Extreme 55.22
83.34
5 years
38.63
Extreme 38.625
83.34
10 years
38.63
Extreme 38.625
83.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-05-31 80.34 +0.17% 6,341,942
24-05-30 80.2 +0.25% 759,990
24-05-29 80 -1.06% 977,244
24-05-28 80.86 -1.73% 904,000
24-05-27 82.28 +0.32% 289,879

Delayed Quote Swiss Exchange, May 31, 2024 at 11:30 am EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.92 USD
Average target price
93.37 USD
Spread / Average Target
+5.01%
Consensus